
Stephen Hahn’s cancer-testing biotech hires a new CMO; Former Iovance exec named CEO of Obsidian
Flagship Pioneering’s blood cancer testing startup Harbinger Health has brought in drug industry veteran May Orfali as its new chief medical officer.
Orfali will be charged with wrapping up a key clinical trial for Harbinger’s test, working closely with ex-FDA head Stephen Hahn, who became the biotech’s CEO in 2021 after leaving the agency.
Orfali has spent more than 25 years working in the industry, including nearly a decade at various roles at Pfizer and most recently as CMO of Sigilon Therapeutics, another Flagship company.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters